HC Wainwright & Co. Maintains Buy on Annexon, Raises Price Target to $25
HC Wainwright & Co. analyst Ananda Ghosh maintains Annexon (NASDAQ:ANNX) with a Buy and raises the price target from $14 to $25.
ANNX is up 6.38% today. Volume is 1.70M vs a 30-day average of 3.63M (0.47x).
Annexon, Inc. is scheduled to report earnings Mon, Nov 16, 2026. Analysts expect EPS of $-0.29. Stocks often move sharply on earnings day.
HC Wainwright & Co. analyst Ananda Ghosh maintains Annexon (NASDAQ:ANNX) with a Buy and raises the price target from $14 to $25.

BRISBANE, Calif., Oct. 16, 2026 (GLOBE NEWSWIRE) -- Annexon, Inc. (Nasdaq: ANNX), a biopharmaceutical company advancing the next generation platform of targeted immunotherapies ai…